Rx/Reimbursement Adult Incontinence in Colombia

In 2023, incontinence Rx/Reimbursement recorded a rate that, although positive, has been the lowest since 2020. Even though these products are covered by MIPRES, a system in which physicians prescribe medicines, nutritional supplements, and diapers for heavy incontinence, the uncertainty and difficulties faced by healthcare providers (EPS) negatively impacted the delivery of incontinence goods.

The Rx/Reimbursement adult incontinence in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2028 illustrate how the market is set to change.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Rx/Reimbursement adult incontinence market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.